GNH USA

Europe — EMA

Kinzalkomb (Hydrochlorothiazide, Telmisartan)

GNH USA supplies Kinzalkomb (Hydrochlorothiazide/Telmisartan), a diuretic and angiotensin II receptor blocker for hypertension. Request a quote for supply.

Hydrochlorothiazide, Telmisartan

Request sourcing

1
Pack/s

What is Hydrochlorothiazide, Telmisartan?

Hydrochlorothiazide and Telmisartan, the active ingredients in Kinzalkomb, are a thiazide diuretic and an angiotensin II receptor blocker presented as an oral tablet for systemic use. They are indicated for the treatment of hypertension in adult patients. The combination enhances blood pressure control by reducing fluid volume and blocking vasoconstrictive pathways, offering a convenient once‑daily regimen for patients requiring dual therapy.

GNH USA supplies Kinzalkomb as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with rigorous quality assurance and regulatory adherence.

What is Hydrochlorothiazide, Telmisartan used for?

Kinzalkomb, a combination antihypertensive, acts on the renin‑angiotensin system and renal sodium handling to lower blood pressure. - Primary hypertension: lowers systolic and diastolic pressure in adults with essential hypertension. - Secondary hypertension: assists in blood pressure control when an underlying cause is identified but pharmacologic management is required. - Hypertension with fluid retention: combines diuretic and ARB effects to improve control in patients with volume overload.

What are the side effects of Hydrochlorothiazide, Telmisartan?

Common Side Effects: - Dizziness - Headache - Increased urination - Fatigue

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Acute kidney injury - Hyperkalemia

What precautions apply to Hydrochlorothiazide, Telmisartan?

Monitor blood pressure: ensure adequate control and avoid hypotension. Check electrolyte levels: especially potassium and sodium during therapy. Assess renal function: periodic testing recommended for patients with kidney disease. Review hepatic status: avoid in severe hepatic impairment. Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

What does Hydrochlorothiazide, Telmisartan interact with?

Major Interactions (Avoid): - Concomitant use with aliskiren in diabetic patients: risk of renal impairment. - Potassium‑sparing diuretics or supplements: may cause hyperkalemia. - NSAIDs: can reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or other ARBs: additive blood pressure lowering. - Lithium: increased lithium levels, monitor for toxicity. - Antidiabetic drugs: may enhance hypoglycemic effect.

Frequently asked questions

What is Kinzalkomb used for?+
Kinzalkomb is a prescription combination of hydrochlorothiazide and telmisartan indicated for the treatment of hypertension in adult patients. The diuretic component helps eliminate excess fluid, while the angiotensin II receptor blocker relaxes blood vessels, together providing effective blood‑pressure control, especially when monotherapy is insufficient.
How does hydrochlorothiazide/telmisartan work?+
Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, promoting diuresis and reducing plasma volume. Telmisartan selectively blocks the AT1 receptor, preventing angiotensin II‑mediated vasoconstriction and aldosterone release. The combined actions lower cardiac output and systemic vascular resistance, resulting in reduced blood pressure.
What is the usual dose of Kinzalkomb?+
The appropriate dose of Kinzalkomb is determined by the prescribing clinician based on the patient’s blood‑pressure profile, renal function, and concomitant medications. Dosage adjustments may be required for special populations, and the medication should be taken exactly as directed on the prescription label.
Is Kinzalkomb safe during pregnancy or breastfeeding?+
Safety of Kinzalkomb in pregnancy has not been established, and it should be used only if the potential benefit justifies the potential risk to the fetus. Breastfeeding is not recommended because the active ingredients can be excreted in milk; alternative therapies should be considered.
How do I order Kinzalkomb from GNH USA?+
To place an order, submit an enquiry on the Kinzalkomb product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Kinzalkomb compare with other antihypertensive options?+
Compared with single‑agent therapy, Kinzalkomb offers the convenience of two complementary mechanisms in one tablet, which can improve adherence and provide synergistic blood‑pressure reduction. It is often preferred over separate prescriptions of a thiazide diuretic and an ARB when combination therapy is indicated, but choice depends on individual patient factors and tolerability.
What are the storage and handling requirements for Kinzalkomb?+
Kinzalkomb tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiration date printed on the label.
How is Kinzalkomb administered?+
Kinzalkomb is taken orally, usually once daily, with or without food, as directed by the prescribing physician. Swallow the tablet whole with a glass of water; do not crush or split the tablet unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Kinzalkomb?+
The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury, and hyperkalemia, which can be life‑threatening if not recognized promptly. Patients should be monitored for signs of rash, swelling, sudden loss of kidney function, or markedly elevated potassium levels and seek immediate medical attention if they occur.
Who should not use Kinzalkomb?+
Kinzalkomb is contraindicated in patients with known hypersensitivity to either hydrochlorothiazide or telmisartan, severe renal impairment, and in those taking aliskiren concomitantly if they have diabetes. Caution is also advised for individuals with hepatic dysfunction, electrolyte disturbances, or a history of angio‑edema. Clinicians must evaluate each patient’s medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Hydrochlorothiazide, Telmisartan
Route
Oral Use
Manufacturer
Bayer Ag
Origin
EU

Related products

Actelsar Hct

Actelsar Hct

Hydrochlorothiazide, Telmisartan

Actavis Group Ptc Ehf.
EU
Actelsar Hct

Actelsar Hct

Hydrochlorothiazide, Telmisartan

Actavis Group Ptc Ehf.
EU
Actelsar Hct

Actelsar Hct

Hydrochlorothiazide, Telmisartan

Actavis Group Ptc Ehf.
EU
Actelsar Hct

Actelsar Hct

Hydrochlorothiazide, Telmisartan

Actavis Group Ptc Ehf.
EU